B. Nardelli, O. Belvedere, V. Roschke, P. Moore, H. Olsen et al., Synthesis and release of B-lymphocyte stimulator from myeloid cells, Blood, vol.97, issue.1, pp.198-204, 2001.
DOI : 10.1182/blood.V97.1.198

P. Schneider, F. Mackay, V. Steiner, K. Hofmann, J. Bodmer et al., BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth, The Journal of Experimental Medicine, vol.85, issue.11, pp.1891747-1756, 1999.
DOI : 10.1126/science.7537388

M. Lopez-fraga, R. Fernandez, J. Albar, and M. Hahne, Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase, EMBO reports, vol.1, issue.8, pp.945-951, 2001.
DOI : 10.1093/embo-reports/kve198

G. Kolfschoten, B. Pradet-balade, M. Hahne, and J. Medema, TWE-PRIL; a fusion protein of TWEAK and APRIL, Biochemical Pharmacology, vol.66, issue.8, pp.661427-1432, 2003.
DOI : 10.1016/S0006-2952(03)00493-3

B. Pradet-balade, J. Medema, M. Lopez-fraga, J. Lozano, G. Kolfschoten et al., An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein, The EMBO Journal, vol.21, issue.21, pp.5711-5720, 2002.
DOI : 10.1093/emboj/cdf565

D. Avery, S. Kalled, J. Ellyard, C. Ambrose, S. Bixler et al., BAFF selectively enhances the survival of plasmablasts generated from human memory B cells, Journal of Clinical Investigation, vol.112, issue.2, pp.286-297, 2003.
DOI : 10.1172/JCI18025

C. Bossen, T. Cachero, A. Tardivel, K. Ingold, L. Willen et al., TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts, Blood, vol.111, issue.3, pp.1004-1012, 2008.
DOI : 10.1182/blood-2007-09-110874

F. Mackay, P. Schneider, P. Rennert, J. Browning, . Baff et al., APRIL: A Tutorial on B Cell Survival, Annual Review of Immunology, vol.21, issue.1, pp.231-264, 2003.
DOI : 10.1146/annurev.immunol.21.120601.141152

M. Hahne, T. Kataoka, M. Schroter, K. Hofmann, M. Irmler et al., APRIL, a new ligand of the tumor necrosis myeloma: a mechanism for growth and survival, Blood, vol.103, issue.2, pp.689-694, 2004.

S. Yaccoby, A. Pennisi, X. Li, S. Dillon, F. Zhan et al., Atacicept (TACI-Ig) inhibits growth of TACIhigh primary myeloma cells in SCID-hu mice and in coculture with osteoclasts, Leukemia, vol.91, issue.2, pp.406-413, 2008.
DOI : 10.1182/blood-2003-11-3839

S. Elsawa, A. Novak, D. Grote, S. Ziesmer, T. Witzig et al., B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia, Blood, vol.107, issue.7, pp.2882-2888, 2006.
DOI : 10.1182/blood-2005-09-3552

J. Hendriks, L. Planelles, J. De-jong-odding, G. Hardenberg, S. Pals et al., Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation, Cell Death and Differentiation, vol.26, issue.6, pp.637-648, 2005.
DOI : 10.1038/sj.cdd.4401647

K. Ingold, A. Zumsteg, A. Tardivel, B. Huard, Q. Steiner et al., Identification of proteoglycans as the APRIL-specific binding partners, The Journal of Experimental Medicine, vol.103, issue.9, pp.1375-1383, 2005.
DOI : 10.1002/eji.1830221136

P. Rennert, P. Schneider, T. Cachero, J. Thompson, L. Trabach et al., A Soluble Form of B Cell Maturation Antigen, a Receptor for the Tumor Necrosis Factor Family Member April, Inhibits Tumor Cell Growth, The Journal of Experimental Medicine, vol.14, issue.11, pp.1921677-1684, 2000.
DOI : 10.1016/S0016-5085(00)70003-5

D. Bischof, S. Elsawa, G. Mantchev, J. Yoon, G. Michels et al., Selective activation of TACI by syndecan-2, Blood, vol.107, issue.8, pp.3235-3242, 2006.
DOI : 10.1182/blood-2005-01-0256

D. Rhodes, J. Yu, K. Shanker, N. Deshpande, R. Varambally et al., Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression, Proceedings of the National Academy of Sciences, vol.101, issue.25, pp.9309-9314, 2004.
DOI : 10.1073/pnas.0401994101

S. Assou, L. Carrour, T. Tondeur, S. Strom, S. Gabelle et al., A Meta-Analysis of Human Embryonic Stem Cells Transcriptome Integrated into a Web-Based Expression Atlas, Stem Cells, vol.22, issue.4, pp.961-973, 2007.
DOI : 10.1634/stemcells.2006-0352
URL : https://hal.archives-ouvertes.fr/inserm-00128925

D. Rhodes, J. Yu, K. Shanker, N. Deshpande, R. Varambally et al., ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform, Neoplasia, vol.6, issue.1, pp.1-6, 2004.
DOI : 10.1016/S1476-5586(04)80047-2

V. Brune, E. Tiacci, I. Pfeil, C. Doring, S. Eckerle et al., Origin and pathogenesis of nodular lymphocyte???predominant Hodgkin lymphoma as revealed by global gene expression analysis, The Journal of Experimental Medicine, vol.57, issue.10, pp.2052251-2268, 2008.
DOI : 10.1084/jem.20020062

M. Bredel, C. Bredel, D. Juric, G. Harsh, H. Vogel et al., Functional Network Analysis Reveals Extended Gliomagenesis Pathway Maps and Three Novel MYC-Interacting Genes in Human Gliomas, Cancer Research, vol.65, issue.19, pp.8679-8689, 2005.
DOI : 10.1158/0008-5472.CAN-05-1204

L. Sun, A. Hui, Q. Su, A. Vortmeyer, Y. Kotliarov et al., Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain, Cancer Cell, vol.9, issue.4, pp.287-300, 2006.
DOI : 10.1016/j.ccr.2006.03.003

Y. Liang, M. Diehn, N. Watson, A. Bollen, K. Aldape et al., Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme, Proceedings of the National Academy of Sciences, vol.102, issue.16, pp.1025814-5819, 2005.
DOI : 10.1073/pnas.0402870102

M. Krumbholz, D. Theil, T. Derfuss, A. Rosenwald, F. Schrader et al., BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma, The Journal of Experimental Medicine, vol.161, issue.2, pp.195-200, 2005.
DOI : 10.1002/jnr.490320405

S. Tschen, S. Stohlman, C. Ramakrishna, D. Hinton, R. Atkinson et al., CNS viral infection diverts homing of antibody-secreting cells from lymphoid organs to the CNS, European Journal of Immunology, vol.58, issue.3, pp.603-612, 2006.
DOI : 10.1002/eji.200535123

A. Richardson, Z. Wang, D. Nicolo, A. Lu, X. Brown et al., X chromosomal abnormalities in basal-like human breast cancer, Cancer Cell, vol.9, issue.2, pp.121-132, 2006.
DOI : 10.1016/j.ccr.2006.01.013

Y. Hao, G. Triadafilopoulos, P. Sahbaie, H. Young, M. Omary et al., Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors, Gastroenterology BMC cancer Cancer Res, vol.131, issue.662, pp.925-93331, 2003.

E. Blaveri, J. Simko, J. Korkola, J. Brewer, F. Baehner et al., Bladder cancer outcome and subtype classification by gene expression, Clin Cancer Res, issue.11, pp.114044-4055, 2005.

M. Sanchez-carbayo, N. Socci, J. Lozano, and F. Saint, Defining Molecular Profiles of Poor Outcome in Patients With Invasive Bladder Cancer Using Oligonucleotide Microarrays, Journal of Clinical Oncology, vol.24, issue.5, pp.778-789, 2006.
DOI : 10.1200/JCO.2005.03.2375

E. Kimchi, M. Posner, J. Park, T. Darga, M. Kocherginsky et al., Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation, Cancer Res, issue.8, pp.653146-3154, 2005.

M. Ginos, G. Page, B. Michalowicz, K. Patel, S. Volker et al., Identification of a Gene Expression Signature Associated with Recurrent Disease in Squamous Cell Carcinoma of the Head and Neck, Cancer Research, vol.64, issue.1, pp.55-63, 2004.
DOI : 10.1158/0008-5472.CAN-03-2144

G. Toruner, C. Ulger, M. Alkan, A. Galante, J. Rinaggio et al., Association between gene expression profile and tumor invasion in oral squamous cell carcinoma. Cancer genetics and cytogenetics, pp.27-35, 2004.

A. Alizadeh, M. Eisen, R. Davis, C. Ma, I. Lossos et al., Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma, Nature N Engl J Med, vol.403, issue.5025, pp.503-511, 2000.

C. Iacobuzio-donahue, A. Maitra, M. Olsen, A. Lowe, N. Van-heek et al., Exploration of Global Gene Expression Patterns in Pancreatic Adenocarcinoma Using cDNA Microarrays, The American Journal of Pathology, vol.162, issue.4, pp.1151-1162, 2003.
DOI : 10.1016/S0002-9440(10)63911-9

W. Freije, F. Castro-vargas, Z. Fang, S. Horvath, T. Cloughesy et al., Gene Expression Profiling of Gliomas Strongly Predicts Survival, Cancer Research, vol.64, issue.18, pp.6503-6510, 2004.
DOI : 10.1158/0008-5472.CAN-04-0452

O. Modlich, H. Prisack, G. Pitschke, U. Ramp, R. Ackermann et al., Identifying Superficial, Muscle-Invasive, and Metastasizing Transitional Cell Carcinoma of the Bladder: Use of cDNA Array Analysis of Gene Expression Profiles, Clinical Cancer Research, vol.10, issue.10, pp.3410-3421, 2004.
DOI : 10.1158/1078-0432.CCR-03-0134

C. Ginestier, N. Cervera, P. Finetti, S. Esteyries, B. Esterni et al., Prognosis and Gene Expression Profiling of 20q13-Amplified Breast Cancers, Clinical Cancer Research, vol.12, issue.15, pp.124533-4544, 2006.
DOI : 10.1158/1078-0432.CCR-05-2339
URL : https://hal.archives-ouvertes.fr/hal-01431971

B. Bachtiary, P. Boutros, M. Pintilie, W. Shi, C. Bastianutto et al., Gene expression profiling in cervical cancer: an exploration of intratumor heterogeneity Clin Cancer Res The source of APRIL up-regulation in human solid tumor lesions Role of the tumour necrosis family ligand APRIL in solid tumour development: Retrospective studies in bladder, ovarian and head and neck carcinomas, J Leukoc Biol Eur J Cancer, vol.12, issue.5815, pp.5632-5640697, 2006.

J. Moreaux, A. Sprynski, K. Mahtouk, P. Moine, N. Robert et al., Binding of TACI and APRIL to Syndecan-1 Confer on Them a Major Role in Multiple Myeloma, ASH Annual Meeting Abstracts, p.1103522, 2007.

F. Zhan, B. Barlogie, V. Arzoumanian, Y. Huang, D. Williams et al., Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis, Blood, vol.109, issue.4, pp.1692-1700, 2007.
DOI : 10.1182/blood-2006-07-037077

Y. Huang, M. Prasad, W. Lemon, H. Hampel, F. Wright et al., Gene expression in papillary thyroid carcinoma reveals highly consistent profiles, Proceedings of the National Academy of Sciences, vol.98, issue.26, pp.9815044-15049, 2001.
DOI : 10.1073/pnas.251547398

S. Dave, K. Fu, G. Wright, L. Lam, P. Kluin et al., Molecular Diagnosis of Burkitt's Lymphoma, New England Journal of Medicine, vol.354, issue.23, pp.3542431-2442, 2006.
DOI : 10.1056/NEJMoa055759

M. Gupta, S. Ansell, T. Witzig, S. Ziesmer, J. Cerhan et al., APRIL-TACI Interactions Mediate Non-Hodgkin Lymphoma B Cell Proliferation through Akt Regulated Cyclin D1 and P21. ASH Annual Meeting Abstracts, p.1103585, 2007.

F. Deshayes, G. Lapree, A. Portier, Y. Richard, P. Pencalet et al., Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor, Oncogene, vol.23, issue.17, pp.233005-3012, 2004.
DOI : 10.1038/sj.onc.1207350

H. Okano, K. Shiraki, Y. Yamanaka, H. Inoue, T. Kawakita et al., Functional expression of a proliferationrelated ligand in hepatocellular carcinoma and its implications for neovascularization, World J Gastroenterol, issue.30, pp.114650-4654, 2005.

J. Couchman, Syndecans: proteoglycan regulators of cell-surface microdomains?, Nature Reviews Molecular Cell Biology, vol.4, issue.12, pp.926-937, 2003.
DOI : 10.1038/nrm1257

J. Filmus, Glypicans in growth control and cancer, Glycobiology, vol.11, issue.3, pp.19-23, 2001.
DOI : 10.1093/glycob/11.3.19R

K. Mahtouk, F. Cremer, T. Reme, J. M. Baudard, M. Moreaux et al., Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma, Oncogene, vol.83, issue.54, pp.257180-7191, 2006.
DOI : 10.1038/sj.onc.1209699
URL : https://hal.archives-ouvertes.fr/inserm-00128880

M. Bernfield, M. Gotte, P. Park, O. Reizes, M. Fitzgerald et al., Functions of Cell Surface Heparan Sulfate Proteoglycans, Annual Review of Biochemistry, vol.68, issue.1, pp.729-777, 1999.
DOI : 10.1146/annurev.biochem.68.1.729

R. Sasisekharan, Z. Shriver, G. Venkataraman, and U. Narayanasami, Roles of heparan-sulphate glycosaminoglycans in cancer, Nature Reviews Cancer, vol.2, issue.7, pp.521-528, 2002.
DOI : 10.1038/nrc842

J. Timar, K. Lapis, J. Dudas, A. Sebestyen, L. Kopper et al., Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer, Seminars in Cancer Biology, vol.12, issue.3, pp.173-186, 2002.
DOI : 10.1016/S1044-579X(02)00021-4

C. Alexander, F. Reichsman, M. Hinkes, J. Lincecum, K. Becker et al., Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice, Nature Genetics, vol.25, issue.3, pp.329-332, 2000.
DOI : 10.1038/77108

C. Klerk, S. Smorenburg, H. Otten, A. Lensing, M. Prins et al., The Effect of Low Molecular Weight Heparin on Survival in Patients With Advanced Malignancy, Journal of Clinical Oncology, vol.23, issue.10, pp.232130-2135, 2005.
DOI : 10.1200/JCO.2005.03.134